Cost‐Effectiveness of a Personalised Self‐Management Intervention for People Living With Long Covid: The LISTEN Randomised Controlled Trial

Guardado en:
Detalles Bibliográficos
Publicado en:Health Expectations vol. 28, no. 4 (Aug 1, 2025)
Autor principal: Harris, Shaun R. S.
Otros Autores: Sewell, Bernadette, Busse‐Morris, Monica, Edwards, Adrian, Jones, Fiona, Leggat, Fiona, Pallman, Philip, Fitzsimmons, Deborah
Publicado:
John Wiley & Sons, Inc.
Materias:
Acceso en línea:Citation/Abstract
Full Text
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 3244247432
003 UK-CbPIL
022 |a 1369-6513 
022 |a 1369-7625 
024 7 |a 10.1111/hex.70357  |2 doi 
035 |a 3244247432 
045 0 |b d20250801 
084 |a 110711  |2 nlm 
100 1 |a Harris, Shaun R. S.  |u Swansea Trials Unit, Swansea University, Swansea, UK 
245 1 |a Cost‐Effectiveness of a Personalised Self‐Management Intervention for People Living With Long Covid: The LISTEN Randomised Controlled Trial 
260 |b John Wiley & Sons, Inc.  |c Aug 1, 2025 
513 |a Journal Article 
520 3 |a ABSTRACT Background In the United Kingdom, at least 1.9 million people are estimated to have experienced long Covid, of which 1.3 million have symptoms lasting for more than a year. The Long CovId Personalised Self‐managemenT support EvaluatioN (LISTEN) trial evaluated the effectiveness and cost‐effectiveness of a co‐designed personalised self‐management support intervention for non‐hospitalised people living with long Covid. Methods We conducted a pragmatic, multicentre, two‐arm, parallel group and superiority randomised controlled trial for people who had experienced at least one long Covid symptom for 12 weeks or longer. A cost–utility analysis was undertaken alongside the LISTEN trial from both a UK National Health Service (NHS) and personal social services (PSS) and a societal perspective. Implementation costs were determined from study records, and quality of life and health and care resource use were collected by questionnaire at 6‐week and 3‐month follow‐ups. Incremental net monetary benefit (INMB) analyses evaluated the cost‐effectiveness of the intervention at a range of willingness‐to‐pay thresholds. Results A total of 544 participants were included in the health economic analysis, of which 62.5% had complete data. The average cost of delivering the LISTEN intervention was £846 per participant. At 3‐month follow‐up, mean quality‐adjusted life years (QALYs) were 0.005 (95% CI −0.004 to 0.014) greater for participants receiving the LISTEN intervention compared to usual care. From the NHS and PSS perspective, total adjusted mean costs were £491 (95% CI, £128 to £854) lower in the usual care arm. From the societal perspective, participants in the usual care arm lost more hours of work and usual activities and received more informal care, with the LISTEN intervention dominating usual care. Conclusions At accepted UK thresholds, the LISTEN intervention was not cost‐effective from an NHS and PSS perspective, but it was found to be cost‐effective from a societal perspective due to the impact of long Covid on work, informal care and usual activities. Further research is required to understand the costs and benefits of self‐management support for longer‐term horizons. Patient and Public Contribution We are grateful for the contributions of the LISTEN Public and Patient Involvement and Engagement group comprising seven people (Anne Domeney, Ian Patel, Carol Rowe, Judith Parsons, Rebecca Beltran, Elizabeth Treadwell and Maria Ines de Sousa de Abreu) with long Covid who supported co‐design, communications, trial recruitment and dissemination activities. Trial Registration ISRCTN36407216, registered 27 January 2022. 
651 4 |a United Kingdom--UK 
651 4 |a England 
651 4 |a Wales 
653 |a Economic analysis 
653 |a Intervention 
653 |a Quality of care 
653 |a Management 
653 |a Questionnaires 
653 |a Health care expenditures 
653 |a Self evaluation 
653 |a Quality of life 
653 |a Social services 
653 |a Health services 
653 |a Registration 
653 |a Cost analysis 
653 |a Recruitment 
653 |a Working hours 
653 |a Effectiveness 
653 |a Self-efficacy 
653 |a Customization 
653 |a Informal care 
653 |a Costs 
653 |a Long COVID 
653 |a Cost of living 
653 |a Books 
653 |a Cost benefit analysis 
653 |a Opportunity costs 
653 |a Co-design 
653 |a Thresholds 
653 |a Dissemination 
653 |a Symptoms 
653 |a Patient participation 
653 |a Patients 
653 |a Utility functions 
653 |a Economic 
653 |a Social 
700 1 |a Sewell, Bernadette  |u Swansea Centre for Health Economics, Swansea University, Swansea, UK 
700 1 |a Busse‐Morris, Monica  |u Centre for Trials Research, School of Medicine, Cardiff University, Cardiff, UK 
700 1 |a Edwards, Adrian  |u PRIME Centre Wales, Division of Population Medicine, School of Medicine, Cardiff University, Cardiff, UK 
700 1 |a Jones, Fiona  |u Population Health Research Institute, St George's, University of London, London, UK 
700 1 |a Leggat, Fiona  |u Population Health Research Institute, St George's, University of London, London, UK 
700 1 |a Pallman, Philip  |u Centre for Trials Research, School of Medicine, Cardiff University, Cardiff, UK 
700 1 |a Fitzsimmons, Deborah  |u Swansea Centre for Health Economics, Swansea University, Swansea, UK 
773 0 |t Health Expectations  |g vol. 28, no. 4 (Aug 1, 2025) 
786 0 |d ProQuest  |t Health & Medical Collection 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3244247432/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/3244247432/fulltext/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3244247432/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch